spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Healthcare News Roundup: Biopharmaceutical

 HSMN NewsFeed - 4 Dec 2023
Sensorium Therapeutics Announces Appointment of Veteran Biotech Executive Alexandra Glucksmann, Ph.D., as CEO as the Company Progresses Toward the Clinic
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Nov 2023
Biolexis Secures $10 Million in Series A Funding to Advance Metabolic Drug Development
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Nov 2023
Novartis Issues Voluntary US Nationwide Recall of Two Lots of Sandimmune(R) Oral Solution (cyclosporine oral solution, USP), 100 mg/mL due to Crystallization
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 22 Nov 2023
Vaccine Partner Valneva receives FDA approval for the World's first chikungunya vaccine using Albumedix' Recombumin(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Nov 2023
FDA Grants Orphan Drug Designation to NeoImmuneTech's NT-I7 for the Treatment of Acute Radiation Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Nov 2023
Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Nov 2023
Mirati Therapeutics Receives Positive Opinion from CHMP for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation Following a Re-Examination Procedure
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 6 Nov 2023
NeuroBo Pharmaceuticals Strengthens Board of Directors with the Appointment of James P. Tursi, M.D.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Nov 2023
Actinium Appoints Lynn Bodarky as Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 Nov 2023
cTRL Therapeutics Appoints Derrell D. Porter, M.D., as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 31 Oct 2023
FDA Approves Novartis Cosentyx(R) as the First New Biologic Treatment Option for Hidradenitis Suppurativa Patients in Nearly a Decade
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Oct 2023
Mozart Therapeutics Expands Executive Leadership Team with Appointments of Dr. Jason Chien, Chief Medical Officer, and Russ Hawkinson, Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Oct 2023
Antiva Biosciences Strengthens Leadership with Key New Appointments
Biopharmaceuticals Personnel
Older Biopharmaceutical stories   Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.